R. Andrew Heyer - 15 Nov 2022 Form 4/A - Amendment Insider Report for biote Corp. (BTMD)

Role: Director
Signature: /s/ Marybeth Conlon, as Attorney-in-Fact for Andrew R. Heyer
Issuer symbol: BTMD
Transactions as of: 15 Nov 2022
Transactions value $: $0
Form type: 4/A - Amendment
Filing time: 18 Nov 2022, 15:06:59
Date Of Original Report: 16 Nov 2022
Previous filing: 03 Oct 2022
Next filing: 20 Jan 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTMD	Stock Option (Right to Buy)	Award	$0	+63.4K		$0.00	63.4K	15 Nov 2022	Class A Common Stock	63.4K	$3.97	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vests in equal monthly installments over a three-year period commencing on June 26, 2022, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

This Amendment to the original Form 4 filed on November 16, 2022 (the "Original Form 4") is being filed solely to correct the exercise price in Column 2 of Table II. All other information in the Original Form 4 remains the same.